Shares of Opus Genetics, Inc. (NASDAQ:IRD – Get Free Report) traded up 2% during mid-day trading on Friday . The stock traded as high as $1.06 and last traded at $1.01. 187,892 shares were traded during trading, a decline of 15% from the average session volume of 220,116 shares. The stock had previously closed at $0.99.
Wall Street Analyst Weigh In
Separately, HC Wainwright reissued a “buy” rating and issued a $8.00 price objective on shares of Opus Genetics in a research note on Wednesday, February 19th.
Opus Genetics Trading Up 2.0 %
Opus Genetics Company Profile
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc, formerly known as Ocuphire Pharma Inc, is based in Farmington Hills, Michigan.
Featured Articles
- Five stocks we like better than Opus Genetics
- What Are Some of the Best Large-Cap Stocks to Buy?
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Industrial Products Stocks Investing
- MarketBeat Week in Review – 03/24 – 03/28
- Upcoming IPO Stock Lockup Period, Explained
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Opus Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opus Genetics and related companies with MarketBeat.com's FREE daily email newsletter.
